Innover, Inc. – Trademark Portfolio
Entity Type: 03
Innover, Inc. owns a portfolio of 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LEAP, ÎNNOVER, INNFERRE, INNORAISE, and N INNFERRE. Of these, 9 are registered. The portfolio spans 6 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 5 (Pharmaceuticals). Headquartered in West Hollywood, CA.
1022 Palm Avenue, Suite 2
West Hollywood, CA 90069
Showing of trademarks Trademarks
Trademark Classifications
Innover, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Innover, Inc. have?
Innover, Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned, 3 cancelled.
What trademark classes does Innover, Inc. file in?
Innover, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Innover, Inc.'s most well-known trademarks?
Innover, Inc.'s registered trademark portfolio includes well-known marks such as LEAP, ÎNNOVER, INNFERRE, INNORAISE, and N INNFERRE. These are among 9 currently registered trademarks in the portfolio.
What is Innover, Inc.'s trademark registration success rate?
Innover, Inc. has a 64% trademark registration rate, with 9 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.